Search Results - "Tinoco, Daniella"

Conditioned Subjective Responses to Socially Relevant Stimuli in Social Anxiety Disorder and Subclinical Social Anxiety by Tinoco-González, Daniella, Fullana, Miquel Angel, Torrents-Rodas, David, Bonillo, Albert, Vervliet, Bram, Pailhez, Guillem, Farré, Magí, Andión, Oscar, Perez, Víctor, Torrubia, Rafael

“…Although enhanced fear conditioning has been implicated in the origins of social anxiety disorder (SAD), laboratory evidence in support of this association is…”
Get full text

Conditioned Fear Acquisition and Generalization in Generalized Anxiety Disorder by Tinoco-González, Daniella, Fullana, Miquel Angel, Torrents-Rodas, David, Bonillo, Albert, Vervliet, Bram, Blasco, María Jesús, Farré, Magí, Torrubia, Rafael

“…Abstract Abnormal fear conditioning processes (including fear acquisition and conditioned fear-generalization) have been implicated in the pathogenesis of…”
Get full text

A neural mediator of human anxiety sensitivity by Harrison, Ben J., Fullana, Miquel A., Soriano-Mas, Carles, Via, Esther, Pujol, Jesus, Martínez-Zalacaín, Ignacio, Tinoco-Gonzalez, Daniella, Davey, Christopher G., López-Solà, Marina, Pérez Sola, Victor, Menchón, José M., Cardoner, Narcís

“…Advances in the neuroscientific understanding of bodily autonomic awareness, or interoception, have led to the hypothesis that human trait anxiety sensitivity…”
Get full text

Methods for Neuroscience Drug Development: Guidance on Standardization of the Process for Defining Clinical Outcome Strategies in Clinical Trials by Zaragoza Domingo, Silvia, Alonso, Jordi, Ferrer, Montse, Acosta, Maria T., Alphs, Larry, Annas, Peter, Balabanov, Pavel, Berger, Anna-Karin, Bishop, Kim I., Butlen-Ducuing, Florence, Dorffner, Georg, Edgar, Chris, de Gracia Blanco, Manuel, Harel, Brian, Harrison, John, Horan, William P., Jaeger, Judith, Kottner, Jan, Pinkham, Amy, Tinoco, Daniella, Vance, Monika, Yavorsky, Christian

“…Neurosciences clinical trials continue to have notoriously high failure rates. Appropriate outcomes selection in early clinical trials is key to maximizing the…”
Get full text